Orthostatic hypotension: A review

被引:63
|
作者
Joseph, Adrien [1 ]
Wanono, Ruben [1 ,2 ]
Flamant, Martin [1 ,2 ,3 ]
Vidal-Petiot, Emmanuelle [1 ,2 ,3 ]
机构
[1] Hop Bichat Claude Bernard, DHU Fire, Serv Physiol, 46 Rue Henri Huchard, F-75018 Paris, France
[2] Univ Paris Diderot, Sorbonne Paris Cite, 46 Rue Henri Huchard, F-75018 Paris, France
[3] Lnserm, U1149, 46 Rue Henri Huchard, F-75018 Paris, France
来源
NEPHROLOGIE & THERAPEUTIQUE | 2017年 / 13卷
关键词
Orthostatic hypotension; Autonomic nervous system; Synucleopathies; Baroreflex; ACUTE AUTONOMIC NEUROPATHY; SYSTOLIC BLOOD-PRESSURE; ARTERIAL BAROREFLEX SENSITIVITY; INAPPROPRIATE SINUS TACHYCARDIA; MULTIPLE SYSTEM ATROPHY; GUILLAIN-BARRE-SYNDROME; POSTURAL HYPOTENSION; PARKINSONS-DISEASE; POSTPRANDIAL HYPOTENSION; ATHEROSCLEROSIS RISK;
D O I
10.1016/j.nephro.2017.01.003
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Orthostatic hypotension, defined by a drop in blood pressure of at least 20 mmHg for systolic blood pressure and at least 10 mmHg for diastolic blood pressure within 3 minutes of standing up, is a frequent finding, particularly in elderly patients. It is associated with a significant increase in morbidity and mortality. Although it is often multifactorial, the first favoring factor is medications. Other etiologies are divided in neurogenic orthostatic hypotension, characterized by autonomic failure due to central or peripheral nervous system disorders, and non-neurogenic orthostatic hypotension, mainly favoured by hypovolemia. Treatment always requires education of the patient regarding triggering situations and physiological countermanoeuvers. Pharmacological treatment may sometimes be necessary and mainly relies on volume expansion by fiudrocortisone and/or a vasopressor agents such as midodrine. There is no predefined blood pressure target, the goal of therapy being the relief of symptoms and fall prevention. (C) 2017 Association Societe de nephrologie. Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:S55 / S67
页数:13
相关论文
共 50 条
  • [1] Orthostatic Hypotension JACC State-of-the-Art Review
    Freeman, Roy
    Abuzinadah, Ahmad R.
    Gibbons, Christopher
    Jones, Pearl
    Miglis, Mitchell G.
    Sinn, Dong In
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (11) : 1294 - 1309
  • [2] Mortality and prognosis in patients with neurogenic orthostatic hypotension
    Maule, Simona
    Milazzo, Valeria
    Maule, Milena Maria
    Di Stefano, Cristina
    Milan, Alberto
    Veglio, Franco
    FUNCTIONAL NEUROLOGY, 2012, 27 (02) : 101 - 106
  • [3] Orthostatic hypotension: Review and expert position statement
    Vidal-Petiot, E.
    Pathak, A.
    Azulay, J. -p.
    Traon, A. Pavy-Le
    Hanon, O.
    REVUE NEUROLOGIQUE, 2024, 180 (1-2) : 53 - 64
  • [4] Morbidity and mortality in orthostatic hypotension
    Farrell, Maureen C.
    Shibao, Cyndya A.
    AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL, 2020, 229
  • [5] A Review of the Etiology, Asssociated Comorbidities, and Treatment of Orthostatic Hypotension
    Perlmuter, Lawrence C.
    Sarda, Garima
    Casavant, Vanessa
    Mosnaim, Aron D.
    AMERICAN JOURNAL OF THERAPEUTICS, 2013, 20 (03) : 279 - 291
  • [6] Orthostatic hypotension: managing a difficult problem
    Jones, Pearl K.
    Shaw, Brett H.
    Raj, Satish R.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2015, 13 (11) : 1263 - 1276
  • [7] Chemical pharmacotherapy for the treatment of orthostatic hypotension
    Cheshire, William P.
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (02) : 187 - 199
  • [8] Treating Lows: Management of Orthostatic Hypotension
    Kulkarni, Spoorthy
    Jenkins, Danny
    Dhar, Arko
    Mir, Fraz
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2024, 84 (03) : 303 - 315
  • [9] Treatment of orthostatic hypotension
    Freeman, R
    SEMINARS IN NEUROLOGY, 2003, 23 (04) : 435 - 442
  • [10] Nonpharmacological treatment, fludrocortisone, and domperidone for orthostatic hypotension in Parkinson's disease
    Schoffer, Kerrie L.
    Henderson, Robert D.
    O'Maley, Karen
    O'Sullivan, John D.
    MOVEMENT DISORDERS, 2007, 22 (11) : 1543 - 1549